MDDA’s highest priority during these times is to make sure that our community has the most accurate and up to date information when it comes to Low protein supply including food, supplements and medication.
MDDA has sought advice from all stakeholders, clinics and suppliers of medicines and supplement/formula/low protein foods.
Below are Supplier Statements:
“Cortex Health is absolutely commitment to supply of both prescription and low protein foods. In this current worldwide state, we are taking extra measures to ensure supply needs. At this point, there is NO shortage of prescription formula & low protein foods from Cambrooke in the US, nor from Cortex. International shipping may be affected and so some particularly popular favour options may be running low – please contact us to discuss. At this point, we are not encouraging stockpiling of prescription nor low protein food items but of course contact us if you have any particular needs or concerns. Cortex Health 1800 FOR PKU (1800 367 758)”
“Nutricia is monitoring the COVID-19 (coronavirus) outbreak very closely in order to assess any potential impact on our business. We have assembled a global team to oversee the company’s response with a particular focus on ensuring the welfare of our teams and the continued, uninterrupted supply of our products to patients and consumers around the world. Working closely with our factories and trusted supply chain partners, we are putting in place measures to maximise the availability of our products in Australia and New Zealand in the coming period. Should any of our customers have concerns or queries about their Nutricia protein substitutes or Loprofin product supply, please contact our Nutricia Clinical Care Line on 1800 060 051 or [email protected]”
“Orpharma is closely following the developments on the outbreak of COVID-19 and is working with its global partners to ensure there is no disruption to the supply of the POA nutritional supplements or the Mevalia low protein foods. At present, we do not foresee any significant impact on the delivery of these products as we hold sufficient stock to cover at least the next 3 months. Contingency measures have been implemented by our partners to ensure uninterrupted supply of the raw materials required to manufacture these products. We encourage patients to order their usual quantities. If you have any questions, please contact Orpharma’s customer service team on +61 3 9863 7411 or [email protected]”
“Vitaflo is closely following developments in the outbreak of Covid-19 and is working in close cooperation with the wider Nestlé Health Science group. At the present time, we do not foresee any potential impact on the supply chain for Vitaflo products. Vitaflo is in regular dialogue with its co-manufacturers and raw material suppliers so that we are in the best possible position to respond quickly to the evolving situation whilst ensuring continued supply of Vitaflo products to our customers. In the meantime, please help us to ensure that supplies are not disrupted by continuing to order Vitaflo’s products in their usual quantities. If you have any questions please contact the Vitaflo Australia customer services team on 03 5229 8222.”
Low Protein Product Supply and Coronavirus